DeepIntent is the leading demand side platform (DSP) purpose-built for pharmaceutical brands and their agencies. Powered by Health Intelligence™, DeepIntent gives healthcare marketers the tools to plan, activate, and measure programmatic advertising campaigns with unmatched precision, all within a privacy-compliant, HIPAA-safe environment. Unlike general-purpose DSPs, DeepIntent is designed specifically for the complexities of healthcare advertising. The platform enables pharmaceutical advertisers to identify and reach verified healthcare professional (HCP) audiences through deterministic HCP targeting, as well as patient audiences at scale, ensuring the right message reaches the right person at the right moment in the care journey. DeepIntent supports omnichannel campaign activation across connected TV (CTV), display, video, audio, digital out-of-home (DOOH), and electronic health records (EHR). This breadth of channel coverage allows pharma brands and agencies to engage both HCPs and patients wherever they consume media, from the living room screen to the point of care. What sets DeepIntent apart is its ability to close the loop between media spend and clinical impact. Through integrations with real-world data sources, the platform measures outcomes including script lift, audience quality, and patient engagement, giving marketers a clear picture of how pharmaceutical advertising investments translate into tangible health and business results. DeepIntent is built with privacy at its core, meeting the strict data requirements of the pharmaceutical and healthcare industries. Marketers can activate campaigns confidently knowing that data handling, audience targeting, and measurement all adhere to HIPAA standards and industry privacy best practices. From brand awareness to HCP detailing to patient support programs, DeepIntent empowers healthcare marketers to drive meaningful outcomes, connecting media strategy to real-world clinical impact at scale.